Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M R Lassen

Showing results (11-20 of 61) with videos related to

Pageof 7
Sort By:
Arthroscopy : the Journal of Arthroscopic & Related Surgery : Official Publication of the Arthroscopy Association of North America and the International Arthroscopy Association|January 1, 1993
Thromboembolic complications after arthroscopy of the kneeK A Poulsen, L C Borris, M R Lassen
The New England Journal of Medicine|January 17, 2002
Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip-fracture surgeryB I Eriksson, K A Bauer, M R Lassen, et al.
The New England Journal of Medicine|January 17, 2002
Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective major knee surgeryK A Bauer, B I Eriksson, M R Lassen, et al.
Journal of Thrombosis and Haemostasis : JTH|August 6, 2008
Differences in urinary prothrombin fragment 1 + 2 levels after total hip replacement in relation to venous thromboembolism and bleeding eventsL C Borris, M Breindahl, M R Lassen, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1991
Experimental and clinical validation of the prophylactic antithrombotic effects of a low molecular weight heparin (enoxaparin)J Fareed, J M Walenga, D Hoppensteadt, et al.
Thrombosis Research|April 1, 1994
Role of tissue factor pathway inhibitor in post surgical deep venous thrombosis (DVT) prophylaxis in patients treated with low molecular weight heparinR Kijowski, D Hoppensteadt, J Walenga, et al.
Journal of Thrombosis and Haemostasis : JTH|November 3, 2009
Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patientsS Schulman, U Angerås, D Bergqvist, et al.
Journal of Thrombosis and Haemostasis : JTH|September 18, 2007
The efficacy and safety of apixaban, an oral, direct factor Xa inhibitor, as thromboprophylaxis in patients following total knee replacementM R Lassen, B L Davidson, A Gallus, et al.
Journal of Thrombosis and Haemostasis : JTH|February 4, 2009
AVE5026, a new hemisynthetic ultra-low-molecular-weight heparin for the prevention of venous thromboembolism in patients after total knee replacement surgery--TREK: a dose-ranging studyM R Lassen, O E Dahl, P Mismetti, et al.
Thrombosis and Haemostasis|June 30, 1989
Comparison of real-time B-mode ultrasonography and bilateral ascending phlebography for detection of postoperative deep vein thrombosis following elective hip surgery. The Venous Thrombosis GroupL C Borris, H M Christiansen, M R Lassen, et al.
Pageof 7

Showing results (11-20 of 61) with videos related to

Sort By:
Pageof 7
Arthroscopy : the Journal of Arthroscopic & Related Surgery : Official Publication of the Arthroscopy Association of North America and the International Arthroscopy Association|January 1, 1993
Thromboembolic complications after arthroscopy of the kneeK A Poulsen, L C Borris, M R Lassen
The New England Journal of Medicine|January 17, 2002
Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip-fracture surgeryB I Eriksson, K A Bauer, M R Lassen, et al.
The New England Journal of Medicine|January 17, 2002
Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective major knee surgeryK A Bauer, B I Eriksson, M R Lassen, et al.
Journal of Thrombosis and Haemostasis : JTH|August 6, 2008
Differences in urinary prothrombin fragment 1 + 2 levels after total hip replacement in relation to venous thromboembolism and bleeding eventsL C Borris, M Breindahl, M R Lassen, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1991
Experimental and clinical validation of the prophylactic antithrombotic effects of a low molecular weight heparin (enoxaparin)J Fareed, J M Walenga, D Hoppensteadt, et al.
Thrombosis Research|April 1, 1994
Role of tissue factor pathway inhibitor in post surgical deep venous thrombosis (DVT) prophylaxis in patients treated with low molecular weight heparinR Kijowski, D Hoppensteadt, J Walenga, et al.
Journal of Thrombosis and Haemostasis : JTH|November 3, 2009
Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patientsS Schulman, U Angerås, D Bergqvist, et al.
Journal of Thrombosis and Haemostasis : JTH|September 18, 2007
The efficacy and safety of apixaban, an oral, direct factor Xa inhibitor, as thromboprophylaxis in patients following total knee replacementM R Lassen, B L Davidson, A Gallus, et al.
Journal of Thrombosis and Haemostasis : JTH|February 4, 2009
AVE5026, a new hemisynthetic ultra-low-molecular-weight heparin for the prevention of venous thromboembolism in patients after total knee replacement surgery--TREK: a dose-ranging studyM R Lassen, O E Dahl, P Mismetti, et al.
Thrombosis and Haemostasis|June 30, 1989
Comparison of real-time B-mode ultrasonography and bilateral ascending phlebography for detection of postoperative deep vein thrombosis following elective hip surgery. The Venous Thrombosis GroupL C Borris, H M Christiansen, M R Lassen, et al.
Pageof 7